Can human papillomavirus testing be done on these samples collected in SurePath vials?
We are looking for a way to test our ASC-US and above cases for HPV. A.Testing for high-risk types of human papillomavirus, or HPV, has gained clinical acceptance in the United States for supplemental testing of women for whom the results of primary cervical cytologic screening are atypical (ASC-US). More recently, HPV DNA co-testing along with cervical cytology has been approved as a sensitive modality for primary screening in women over the age of 30. Testing for HPV provides guidance as to how these patients should be managed. According to 2001 American Society for Colposcopy and Cervical Pathology guidelines, testing for high-risk HPV DNA is preferred for triage management, and HPV DNA testing should be performed using a sensitive molecular technique. Available methods for testing for HPV DNA include Hybrid Capture 2 (HC2) DNA Assay, chromogenic in situ hybridization methodology, such as Inform, or PCR techniques. The only FDA-approved in vitro diagnostic test for HPV DNA is the HC
